Prevalence and clinical correlates of subclinical hypothyroidism in non dialysis chronic kidney disease patients: A cross-sectional study
International Journal of Drug Delivery Technology · 01.07.2026 · 16 (60s)
DOI: 10.25258/ijddt.16.60s.80 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 01.07.2026. Verfasst von Mani Srikanth Manam und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Chronic kidney disease (CKD) is frequently associated with endocrine disturbances, particularly thyroid dysfunction. Subclinical hypothyroidism (SCH), characterized by elevated thyroid-stimulating hormone (TSH) levels with normal free T3 and T4, is increasingly recognized in CKD patients. Even mild thyroid dysfunction may contribute to anemia, impaired renal function, and increased cardiovascular risk. However, its prevalence and clinical associations in non-dialysis CKD patients remain inadequately explored.
Aim
To determine the prevalence of subclinical hypothyroidism in non-dialysis CKD patients and evaluate its clinical correlates.
Objectives
To estimate the prevalence of SCH in CKD stage 3–5 patients. To assess the correlation between serum TSH and estimated glomerular filtration rate (eGFR). To evaluate the association between TSH and hemoglobin levels. To determine the relationship between SCH and type 2 diabetes mellitus. Materials and methods This cross-sectional study was conducted over a period of 6 months in the outpatient department of Meenakshi Medical College Hospital and Research Institute, Kanchipuram. A total of 120 adult patients diagnosed with CKD stage 3–5 and not on dialysis were included. Serum TSH, free T3, free T4, serum creatinine, hemoglobin, and HbA1c were measured. eGFR was calculated using the CKD-EPI equation. Subclinical hypothyroidism was defined as TSH >5.5 mIU/L with normal free T3 and free T4 levels. Statistical analysis was performed to assess correlations and associations, with p < 0.05 considered significant.
Results
Out of 120 CKD patients, 34 were found to have subclinical hypothyroidism, giving a prevalence of 28.3%. The prevalence of SCH increased progressively with advancing CKD stage, being highest in stage 5 patients. A significant negative correlation was observed between serum TSH and eGFR (r = −0.41, p < 0.001). Patients with SCH had lower mean hemoglobin levels (9.2 ± 1.1 g/dL) compared to euthyroid patients (10.5 ± 1.3 g/dL, p < 0.001). SCH was more prevalent among patients with type 2 diabetes mellitus (22/60, 36.7%) compared to non-diabetic patients (12/60, 20.0%), showing a significant association.
Conclusion
Subclinical hypothyroidism is common among non-dialysis CKD patients and shows a strong association with declining renal function, anemia, and type 2 diabetes mellitus. Early identification and management of SCH may help in reducing adverse clinical outcomes in CKD patients
Zitieren
APA
Manam, M. S., Sai, P. Y. K., Raya, S., & Anbarasu, D. (2026). Prevalence and clinical correlates of subclinical hypothyroidism in non dialysis chronic kidney disease patients: A cross-sectional study. International Journal of Drug Delivery Technology, 16(60s). https://doi.org/10.25258/ijddt.16.60s.80
Vancouver
Manam MS, Sai PYK, Raya S, Anbarasu D. Prevalence and clinical correlates of subclinical hypothyroidism in non dialysis chronic kidney disease patients: A cross-sectional study. International Journal of Drug Delivery Technology. 2026;16(60s). doi:10.25258/ijddt.16.60s.80
BibTeX
@article{Manam2026,
author = {Manam, Mani Srikanth and Sai, P. Yashwanth Krishna and Raya, Sravani and Anbarasu, Duraisamy},
title = {Prevalence and clinical correlates of subclinical hypothyroidism in non dialysis chronic kidney disease patients: A cross-sectional study},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {60s},
doi = {10.25258/ijddt.16.60s.80}
}
EUVIMED